Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TYO/4538 stock hub

TYO/4538 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TYO/4538is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.8B

Tokyo Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TYO/4538

In the news

Latest news · TYO/4538

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.7P50 15.8P75 21.7

Trailing P/E9.1

P25 11.7P50 15.2P75 22.3

ROEn/a

P25 -1.6P50 7.1P75 11.9

ROIC3.6

P25 -0.6P50 6.2P75 14.3

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TYO/4538 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

JPY

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	JP
Employees	1,370
Employees Change	-2%
Employees Change Percent	-0.15
Enterprise value	JPY 45.6B
Exchange	Tokyo Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	JP3823600006
Last refreshed	2026-05-10
Market cap	JPY 18.8B
Price	JPY 2,198
Price currency	JPY
Rev Per Employee	45,378,832.12x
Sector	Healthcare
Sic	2834
Symbol	tyo/4538
Website	https://www.fuso-pharm.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.99%
EV Earnings	22.12x
EV/EBIT	15.91x
EV/Sales	0.73x
P/B ratio	0.54x
P/E ratio	9.1x
P/S ratio	0.3x
PE Ratio10 Y	69.31x
PE Ratio3 Y	21.9x
PE Ratio5 Y	22.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.61%
Gross margin	26.39%
Gross Profit	JPY 16.4B
Gross Profit Growth	18.53%
Gross Profit Growth Q	4.96%
Gross Profit Growth3 Y	7.03%
Gross Profit Growth5 Y	3.31%
Net Income	JPY 2.1B
Net Income Growth	49.75%
Net Income Growth Q	-5.54%
Net Income Growth Years	0%
Net Income Growth3 Y	23.34%
Pretax Margin	4.42%
Profit Margin	3.32%
Profit Per Employee	JPY 1.5M
ROCE	7.45
ROIC	3.57
Roic5y	4.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.44%
Cagr15y	2.36%
Cagr1y	-4.29%
Cagr20y	-1.12%
Cagr3y	6.23%
Cagr5y	0.99%
Div CAGR10	1.18%
Div CAGR3	8.74%
Div CAGR5	8.45%
EPS Growth	50.99
EPS Growth Q	-5.48
EPS Growth Years	0
EPS Growth3 Y	25.78
Revenue Growth	12.2x
Revenue Growth Q	12.69x
Revenue Growth Quarters	14x
Revenue Growth Years	7x
Revenue Growth3 Y	10.69x
Revenue Growth5 Y	6.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	JPY 89.4B
Cash	JPY 6.9B
Current Assets	JPY 56.6B
Current Liabilities	JPY 51B
Debt	JPY 33.7B
Debt Equity	JPY 0.97
Equity	JPY 34.7B
Interest Coverage	10.38
Liabilities	JPY 54.8B
Long Term Assets	JPY 32.8B
Long Term Liabilities	JPY 3.8B
Net Cash	JPY -26.8B
Net Cash By Market Cap	JPY -143
Net Debt Equity	JPY 0.77
Tangible Book Value	JPY 33.3B
Tangible Book Value Per Share	JPY 3,896
WACC	2.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.11
Net Working Capital	JPY 30.4B
Quick ratio	0.63
Working Capital	JPY 5.7B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.83%
Dividend Growth	9.76%
Dividend Growth Years	1%
Dividend per share	JPY 90
Dividend Years	35
Dividend Yield	4.09%
Ex Div Date	2026-03-30
Last Dividend	JPY 45
Payout Frequency	Semi-Annual
Payout Ratio	37.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	15.39%
1Y total return	-4.29%
200-day SMA	2,253.6
3Y total return	19.87%
50-day SMA	2,359
50-day SMA vs 200-day SMA	50over200
5Y total return	5.03%
All Time High	11,300
All Time High Change	-80.55%
All Time High Date	1993-10-05
All Time Low	1,320
All Time Low Change	66.52%
All Time Low Date	2020-03-13
ATR	32.4
Beta	0.15
Beta1y	0.08
Beta2y	0.34
Ch YTD	-5.05
High	2,231
High52	2,530
High52 Date	2026-03-06
High52ch	-13.12%
Low	2,195
Low52	2,070
Low52 Date	2025-07-08
Low52ch	6.18%
Ma50ch	-6.82%
Price vs 200-day SMA	-2.47%
RSI	29.47
RSI Monthly	47.2
RSI Weekly	41.21
Sharpe ratio	-0.19x
Sortino ratio	0.06
Total Return	4.92%
Tr YTD	-3.26
Tr15y	41.96%
Tr1m	-5.79%
Tr1w	-1.48%
Tr3m	-4.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	JPY 2.9B
Operating Income Growth	45.78
Operating Income Growth Q	-12.68
Operating Income Growth3 Y	16.75
Operating Income Growth5 Y	61.36
Operating margin	4.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,303,044%
Shares Insiders	2.28%
Shares Institutions	21.28%
Shares Out	8,537,644
Shares Qo Q	-0.01%
Shares Yo Y	-0.83%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	18,520x
Bv Per Share	4,059.1
Ch10y	-14.47
Ch15y	-7.26
Ch1m	-5.79
Ch1w	-1.48
Ch1y	-7.99
Ch20y	-52.93
Ch3m	-6.19
Ch3y	7.85
Ch5y	-11.01
Ch6m	3.58
Change	-1.48%
Change From Open	-1.21
Close	2,231
Days Gap	-0.27
Dollar Volume	69,676,600
Earnings Date	2026-05-12
EBIT	JPY 2.9B
EPS	JPY 241
F Score	3
Fiscal Year End	March
Founded	1,937
Graham Number	4696.06734
Graham Upside	113.7
Income Tax	JPY 684M
Is Primary Listing	1
Last Earnings Date	2026-02-12
Last Report Date	2025-12-31
Last Split Date	2016-09-28
Last Split Type	Reverse
Lynch Fair Value	JPY 5,635
Lynch Upside	156.4
Ma150	2,278.9
Ma150ch	-3.55%
Ma20	2,267.1
Ma20ch	-3.05%
Next Earnings Date	2026-05-12
Open	2,225
Payment Date	2026-06-26
Position In Range	8.33
Ppne	22,343,000,000
Price Date	2026-05-08
Ptbv Ratio	0.56
Relative Volume	1.83x
Revenue	62,169,000,000x
Tax By Revenue	1.1x
Tax Rate	24.91%
Tr20y	-20.09%
Tr6m	5.54%
Volume	31,700
Z Score	1.3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TYO/4538 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.1%

$90.0 annual per share

Payout ratio

+37.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+8.4%

1 consecutive years of growth

Total shareholder yield

+4.9%

Next ex-dividend date: 2026-03-30

Performance

TYO/4538 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TYO/4538?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.3%

Share of float held by funds and institutions

Insider ownership

+2.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

TYO/4538 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

29.5

Below 30: short-term oversold

Price vs 200-day MA

-2.5%

50/200-day relationship not available

Beta (5Y)

0.15

Less volatile than the market

Sharpe ratio

-0.19

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TYO/4538

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/4538 stock rating?

tyo/4538 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/4538 analysis?

The full report lives at /stocks/tyo/4538/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/4538?

The latest report frames tyo/4538 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/4538 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.